Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Dealmaking Moves The Needle Forward

Dec 08 2016

• By Amanda Micklus

DMHC_1200x675

Related Content

New $350m Site To Build Pfizer’s China Biosimilar Capacity

Jun 28 2016

Shire Exits Biosimilars, Streamlines Oncology Business

Nov 02 2016

Teva’s 'Key Ingredient' For Growth: Biosimilars

Sep 13 2016

Related Companies

Novartis AG

Pfizer Inc.

Coherus Oncology, Inc.

EPIRUS Biopharmaceuticals, Inc.

Outlook Therapeutics, Inc.

Teva Pharmaceutical Industries Ltd.

Amgen, Inc.

Hospira, Inc.

STADA Arzneimittel AG

Celltrion, Inc.

Merck & Co., Inc.

Baxalta Incorporated

Allergan plc

Baxter International Inc.

Momenta Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Biogen, Inc.

Additional Topics

Biosimilars Deals Market Intelligence BioPharmaceutical

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window